People with ADHD are more likely to use cannabis but little is known about the effects of cannabis on ADHD symptoms, ADHD medication side effects, or ADHD-related executive dysfunction.
Method:
Students (n = 1,738) completed an online survey containing measures of ADHD symptoms, cannabis use, perceived effects of cannabis on ADHD symptoms and medication side effects, as well as executive dysfunction.
Results:
Participants with ADHD who have used cannabis reported that cannabis has acute beneficial effects on many symptoms of ADHD (e.g., hyperactivity, impulsivity). Further, they perceived cannabis to improve most of their medication side effects (e.g., irritability, anxiety). Finally, cannabis use frequency was a significant moderator of the associations between symptom severity and executive dysfunction.
Conclusion:
Results suggest people with ADHD may be using cannabis to self-medicate for many of their symptoms and medication side effects and that more frequent use may mitigate ADHD-related executive dysfunction.
AdamsonS. J.Kay-LambkinF. J.BakerA. L.LewinT. J.ThorntonL.KellyB. J.SellmanJ. D. (2010). An improved brief measure of cannabis misuse: The cannabis use disorders identification test-revised (CUDIT-R). Drug and Alcohol Dependence, 110(1–2), 137–143. https://doi.org/10.1016/j.drugalcdep.2010.02.017
2.
AlmeidaP. P.NovaesM. A. F. P.BressanR. A.LacerdaA. L. T. D. (2008). Revisão: Funcionamento executivo e uso de maconha. Brazilian Journal of Psychiatry, 30, 69–76. https://doi.org/10.1590/s1516-44462008000100013
3.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed.). American Psychiatric Association.
BeckerS. P.LangbergJ. M. (2014). Attention-Deficit/Hyperactivity disorder and sluggish cognitive tempo dimensions in relation to executive functioning in adolescents with ADHD. Child Psychiatry and Human Development, 45(1), 1–11. https://doi.org/10.1007/s10578-013-0372-z
6.
BennettP. C.OngB.PonsfordJ. (2005). Measuring executive dysfunction in an acute rehabilitation setting: Using the dysexecutive questionnaire (DEX). Journal of the International Neuropsychological Society, 11(4), 376–385. https://doi.org/10.1017/S1355617705050423
7.
BermanS. M.KuczenskiR.McCrackenJ. T.LondonE. D. (2009). Potential adverse effects of amphetamine treatment on brain and behavior: A review. Molecular Psychiatry, 14(2), 123–142. https://doi.org/10.1038/mp.2008.90
8.
BidwellL. C.HenryE. A.WillcuttE. G.KinnearM. K.ItoT. A. (2014). Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students. Drug and Alcohol Dependence, 135(1), 88–94. https://doi.org/10.1016/j.drugalcdep.2013.11.013
9.
BoehnkeK. F.McAfeeJ.AckermanJ. M.KrugerD. J. (2021). Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic. International Journal of Drug Policy, 92, 103053. https://doi.org/10.1016/j.drugpo.2020.103053
10.
Bonn-MillerM. O.BodenM. T.BucossiM. M.BabsonK. A. (2014). Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. The American Journal of Drug and Alcohol Abuse, 40(1), 23–30. https://doi.org/10.3109/00952990.2013.821477
11.
BossongM. G.JagerG.BhattacharyyaS.AllenP. (2014). Acute and non-acute effects of cannabis on human memory function: A critical review of neuroimaging studies. Current Pharmaceutical Design, 20(13), 2114–2125. https://doi.org/10.2174/13816128113199990436
12.
BrandtA.RehmJ.Lev-RanS. (2018). Clinical correlates of cannabis use among individuals with attention deficit hyperactivity disorder. The Journal of Nervous and Mental Disease, 206(9), 726–732. https://doi.org/10.1097/NMD.0000000000000877
13.
BritchS. C.WileyJ. L.YuZ.ClowersB. H.CraftR. M. (2017). Cannabidiol-Δ9-tetrahydrocannabinol interactions on acute pain and locomotor activity. Drug and Alcohol Dependence, 175, 187–197. https://doi.org/10.1016/j.drugalcdep.2017.01.046
14.
BroydS. J.van HellH. H.BealeC.YücelM.SolowijN. (2016). Acute and chronic effects of cannabinoids on human Cognition-A systematic review. Biological Psychiatry, 79(7), 557–567. https://doi.org/10.1016/j.biopsych.2015.12.002
15.
CharachA.YeungE.ClimansT.LillieE. (2011). Childhood attention-deficit/hyperactivity disorder and future substance use disorders: Comparative meta-analyses. Journal of the American Academy of Child and Adolescent Psychiatry, 50(1), 9–21. https://doi.org/10.1016/j.jaac.2010.09.019
16.
ChoiS.HuangB. C.GamaldoC. E. (2020). Therapeutic uses of cannabis on sleep disorders and related conditions. Journal of Clinical Neurophysiology, 37(1), 39–49. https://doi.org/10.1097/WNP.0000000000000617
17.
CooperR. E.WilliamsE.SeegobinS.TyeC.KuntsiJ.AshersonP. (2017). Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial. European Neuropsychopharmacology, 27(8), 795–808. https://doi.org/10.1016/j.euroneuro.2017.05.005
18.
CraneN. A.SchusterR. M.Fusar-PoliP.GonzalezR. (2013). Effects of cannabis on neurocognitive functioning: Recent advances, neurodevelopmental influences, and sex differences. Neuropsychology Review, 23(2), 117–137. https://doi.org/10.1007/s11065-012-9222-1
19.
CranfordJ. A.ArnedtJ. T.ConroyD. A.BohnertK. M.BourqueC.BlowF. C.IlgenM. (2017). Prevalence and correlates of sleep-related problems in adults receiving medical cannabis for chronic pain. Drug and Alcohol Dependence, 180, 227–233. https://doi.org/10.1016/j.drugalcdep.2017.08.017
20.
CreanR. D.CraneN. A.MasonB. J. (2011). An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. Journal of Addiction Medicine, 5(1), 1–8. https://doi.org/10.1097/ADM.0b013e31820c23fa
21.
CuttlerC.SpradlinA. (2017). Measuring cannabis consumption: Psychometric properties of the daily sessions, frequency, age of onset, and quantity of cannabis use inventory (DFAQ-CU). PLoS One, 12(5), e0178194.
22.
CuttlerC.SpradlinA.ClevelandM. J.CraftR. M. (2020). Short- and long-term effects of cannabis on headache and migraine. Journal of Pain, 21(5–6), 722–730. https://doi.org/10.1016/j.jpain.2019.11.001
23.
CuttlerC.SpradlinA.McLaughlinR. J. (2018). A naturalistic examination of the perceived effects of cannabis on negative affect. Journal of Affective Disorders, 235, 198–205. https://doi.org/10.1016/j.jad.2018.04.054
24.
De AlwisD.LynskeyM. T.ReiersenA. M.AgrawalA. (2014). Attention-deficit/hyperactivity disorder subtypes and substance use and use disorders in NESARC. Addictive Behaviors, 39(8), 1278–1285. https://doi.org/10.1016/j.addbeh.2014.04.003
25.
DoremusJ. M.StithS. S.VigilJ. M. (2019). Using recreational cannabis to treat insomnia: Evidence from over-the-counter sleep aid sales in Colorado. Complementary Therapies in Medicine, 47, 102207. https://doi.org/10.1016/j.ctim.2019.102207
26.
DorrM. M.ArmstrongK. J. (2019). Executive functioning and impairment in emerging adult college students with ADHD symptoms. Journal of Attention Disorders, 23(14), 1759–1765. https://doi.org/10.1177/1087054718787883
27.
D’SouzaD. C.RanganathanM.BraleyG.GueorguievaR.ZimoloZ.CooperT.PerryE.KrystalJ. (2008). Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology, 33(10), 2505–2516. https://doi.org/10.1038/sj.npp.1301643
28.
ElkinsI. J.McGueM.IaconoW. G. (2007). Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Archives of General Psychiatry, 64(10), 1145–1152. https://doi.org/10.1001/archpsyc.64.10.1145
FigueiredoP. R.TolomeoS.SteeleJ. D.BaldacchinoA. (2020). Neurocognitive consequences of chronic cannabis use: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews, 108, 358–369. https://doi.org/10.1016/j.neubiorev.2019.10.014
31.
GajriaK.LuM.SikiricaV.GrevenP.ZhongY.QinP.XieJ. (2014). Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder - a systematic literature review. Neuropsychiatric Disease and Treatment, 10, 1543–1569. https://doi.org/10.2147/NDT.S65721
32.
GomezR.StavropoulosV.WatsonS. (2020). Measurement invariance across adult self-ratings of current and retrospective childhood ADHD symptoms. Journal of Psychopathology and Behavioral Assessment, 42, 475–487. https://doi.org/10.1007/s10862-020-09802-x
33.
GruberS. A.SagarK. A.DahlgrenM. K.GonencA.SmithR. T.LambrosA. M.CabreraK. B.LukasS. E. (2017). The grass might be greener: Medical marijuana patients exhibit altered brain activity and improved executive function after 3 months of treatment. Frontiers in Pharmacology, 8, 983. https://doi.org/10.3389/fphar.2017.00983
34.
GruberS. A.SagarK. A.DahlgrenM. K.RacineM. T.SmithR. T.LukasS. E. (2016). Splendor in the grass? A pilot study assessing the impact of medical marijuana on executive function. Frontiers in Pharmacology, 7, 355. https://doi.org/10.3389/fphar.2016.00355
35.
GudjonssonG. H.WellsJ.YoungS. (2012). Personality disorders and clinical syndromes in ADHD prisoners. Journal of Attention Disorders, 16(4), 304–313. https://doi.org/10.1177/1087054710385068
36.
HaneyM.WardA. S.ComerS. D.FoltinR. W.FischmanM. W. (1999). Abstinence symptoms following smoked marijuana in humans. Psychopharmacology, 141(4), 395–404. https://doi.org/10.1007/s002130050849
37.
HayesA. (2017). Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. The Guilford Press.
38.
ImtiazS.WellsS.RehmJ.HamiltonH. A.NigatuY. T.WickensC. M.JankowiczD.Elton-MarshallT. (2020). Cannabis use during the COVID-19 pandemic in Canada. Journal of addiction medicine. Advance online publication, Publish Ahead of Print. https://doi.org/10.1097/ADM.0000000000000798
39.
JagerG.KahnR. S.Van Den BrinkW.Van ReeJ. M.RamseyN. F. (2006). Long-term effects of frequent cannabis use on working memory and attention: An fMRI study. Psychopharmacology, 185, 358–368. https://doi.org/10.1007/s00213-005-0298-7
40.
KesslerR. C.AdlerL.BarkleyR.BiedermanJ.ConnersC. K.DemlerO.FaraoneS. V.GreenhillL. L.HowesM. J.SecnikK.SpencerT.UstunT. B.WaltersE. E.ZaslavskyA. M. (2006). The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey replication. American Journal of Psychiatry, 163(4), 716–723. https://doi.org/10.1176/ajp.2006.163.4.716
41.
LaFranceE. M.StueberA.GlodoskyN. C.MauzayD.CuttlerC. (2020). Overbaked: Assessing and predicting acute adverse reactions to cannabis. Journal of Cannabis Research, 2(1), 3–3. https://doi.org/10.1186/s42238-019-0013-x
42.
LakhanS. E.KirchgessnerA. (2012). Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: Misuse, cognitive impact, and adverse effects. Brain and Behavior, 2(5), 661–677. https://doi.org/10.1002/brb3.78
43.
LeeS. S.HumphreysK. L.FloryK.LiuR.GlassK. (2011). Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: A meta-analytic review. Clinical Psychology Review, 31(3), 328–341. https://doi.org/10.1016/j.cpr.2011.01.006
44.
LilienfeldS. O.AndrewsB. P. (1996). Development and preliminary validation of a self-report measure of psychopathic personality traits in noncriminal populations. Journal of Personality Assessment, 66(3), 488–524. https://doi.org/10.1207/s15327752jpa6603_3
45.
LisdahlK. M.TammL.EpsteinJ. N.JerniganT.MolinaB. S.HinshawS. P.SwansonJ. M.NewmanE.KellyC.BjorkJ.M.; MTA Neuroimaging Group, & MTA. (2016). The impact of ADHD persistence, recent cannabis use, and age of regular cannabis use onset on subcortical volume and cortical thickness in young adults. Drug and Alcohol Dependence, 161, 135–146. https://doi.org/10.1016/j.drugalcdep.2016.01.032
46.
LynchR.KistnerJ. A. N. E. T. A.SaraH. A. R. T.MichaelK. O. F. L. E. R.InsuP. A. E. K.SchatschneiderC. (2017). The psychometric properties of the Barkley adult ADHD rating scale: IV (BAARS-IV) in a college sample. ProQuest dissertations publishing. Retrieved from http://search.proquest.com/docview/2018319314/
47.
ManK. K. C.CoghillD.ChanE. W.LauW. C. Y.HollisC.LiddleE.BanaschewskiT.McCarthyS.NeubertA.SayalK.IpP.SchuemieM. J.SturkenboomM. C. J. M.Sonuga-BarkeE.BuitelaarJ.CarucciS.ZuddasA.KovshoffH.GarasP., . . .WongI. C. K. (2017). Association of risk of suicide attempts with methylphenidate treatment. JAMA Psychiatry, 74(10), 1048–1055. https://doi.org/10.1001/jamapsychiatry.2017.2183
48.
MarcusD. K.BarryT. D. (2011). Does attention-deficit/hyperactivity disorder have a dimensional latent structure? A taxometric analysis. Journal of Abnormal Psychology, 120(2), 427–442. https://doi.org/10.1037/a0021405
49.
MilzE.GrotenhermenF. (2015). Successful therapy of treatment resistant adult ADHD with cannabis: Experience from a medical practice with 30 patients. International Cannabinoid in Medicine and Research Conference, Sestri Levante, Italy.
50.
MitchellJ. T.SweitzerM. M.TunnoA. M.KollinsS. H.McClernonF. J. (2016). “I use weed for my ADHD”: A qualitative analysis of online forum discussions on cannabis use and ADHD. PLoS One, 11(5), e0156614. https://doi.org/10.1371/journal.pone.0156614
51.
MitchellJ. T.WeisnerT. S.JensenP. S.MurrayD. W.MolinaB. S. G.ArnoldL. E.HechtmanL.SwansonJ. M.HinshawS. P.VictorE. C.KollinsS. H.WellsK. C.BelendiukK. A.BlondeA.NguyenC.AmbrizL.NguyenJ. L. (2018). How substance users with ADHD perceive the relationship between substance use and emotional functioning. Journal of Attention Disorders, 22, 49S–60S. https://doi.org/10.1177/1087054716685842
52.
NotzonD. P.PavlicovaM.GlassA.MarianiJ. J.MahonyA. L.BrooksD. J.LevinF. R. (2020). ADHD is highly prevalent in patients seeking treatment for cannabis use disorders. Journal of Attention Disorders, 24(11), 1487–1492. https://doi.org/10.1177/1087054716640109
53.
PolanczykG.de LimaM. S.HortaB. L.BiedermanJ.RohdeL. A. (2007). The worldwide prevalence of ADHD: A systematic review and meta-regression analysis. American Journal of Psychiatry, 164(6), 942–948. https://doi.org/10.1176/ajp.2007.164.6.942
54.
PolanczykG. V.WillcuttE. G.SalumG. A.KielingC.RohdeL. A. (2014). ADHD prevalence estimates across three decades: An updated systematic review and meta-regression analysis. International Journal of Epidemiology, 43(2), 434–442. https://doi.org/10.1093/ije/dyt261
55.
RamaekersJ.KauertG.TheunissenE.ToennesS.MoellerM. (2009). Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. Journal of Psychopharmacology, 23(3), 266–277. https://doi.org/10.1177/0269881108092393
56.
RamaekersJ. G.TheunissenE. L.de BrouwerM.ToennesS. W.MoellerM. R.KauertG. (2011). Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Psychopharmacology, 214(2), 391–401. https://doi.org/10.1007/s00213-010-2042-1
57.
RasmussenJ.CaseyB. J.van ErpT. G.TammL.EpsteinJ. N.BussC.BjorkJ. M.MolinaB. S.VelanovaK.MathalonD. H.SomervilleL.SwansonJ. M.WigalT.ArnoldL. E.PotkinS.G.; MTA Neuroimaging Group. (2016). ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task. Brain Imaging and Behavior, 10(3), 761–771. https://doi.org/10.1007/s11682-015-9438-9
58.
Schramm-SapytaN. L.ChaY. M.ChaudhryS.WilsonW. A.SwartzwelderH. S.KuhnC. M. (2007). Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats. Psychopharmacology, 191(4), 867–877. https://doi.org/10.1007/s00213-006-0676-9
59.
SchwarzN.SudmanS. (Eds.). (1994). Autobiographical memory and the validity of retrospective reports. Springer Science & Business Media.
60.
SextonM.CuttlerC.FinnellJ. S.MischleyL. K. (2016). A cross-sectional survey of medical cannabis users: Patterns of use and perceived efficacy. Cannabis and Cannabinoid Research, 1(1), 131–138. https://doi.org/10.1089/can.2016.0007
61.
SharpeL.SinclairJ.KramerA.de ManincorM.SarrisJ. (2020). Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties. Journal of Translational Medicine, 18, 374. https://doi.org/10.1186/s12967-020-02518-2
62.
ShawS.OeiT. P. S.SawangS. (2015). Psychometric validation of the dysexecutive questionnaire (DEX). Psychological Assessment, 27(1), 138–147. https://doi.org/10.1037/a0038195
63.
Soler ArtigasM.Sánchez-MoraC.RoviraP.RicharteV.Garcia-MartínezI.PagerolsM.DemontisD.StringerS.VinkJ. M.BørglumA. D.NealeB. M.FrankeB.FaraoneS. V.CasasM.Ramos-QuirogaJ. A.RibasésM. (2021). Correction to: attention-deficit/hyperactivity disorder and lifetime cannabis use: Genetic overlap and causality. Molecular Psychiatry, 29(S4), s1108–s1108. https://doi.org/10.1038/s41380-021-01049-6
64.
SolowijN.BattistiR. (2008). The chronic effects of cannabis on memory in humans: A review. Current Drug Abuse Reviews, 1(1), 81–98. https://doi.org/10.2174/1874473710801010081
Substance Abuse and Mental Health Services Administration (SAMHSA). (2016). Marijuana (cannabis). Retrieved from: https://www.samhsa.gov/atod/marijuana.
67.
SwansonJ. M.WigalT.JensenP.MitchellJ. T.WeisnerT. S.MurrayD. W.ArnoldL. E.HechtmanL.MolinaB. S.OwensE.BelendiukK.HowardA. L.WigalS.SorensonP.StehliA. (2017). The qualitative interview study of persistent and non-persistent substance use in the MTA: Sample characteristics, frequency of use, and reasons for use 05-07-17. Journal of Attention Disorders, 22(9 Suppl), 21S–37S. https://doi.org/10.1177/1087054717714058
68.
TammL.EpsteinJ. N.LisdahlK. M.MolinaB.TapertS.HinshawS. P.ArnoldL. E.VelanovaK.AbikoffH.SwansonJ. M. (2013). Impact of ADHD and cannabis use on executive functioning in young adults. Drug and Alcohol Dependence, 133(2), 607–614. https://doi.org/10.1016/j.drugalcdep.2013.08.001
69.
UpadhyayaH. P.CarpenterM. J. (2008). Is attention deficit hyperactivity disorder (ADHD) symptom severity associated with tobacco use?American Journal on Addictions, 17(3), 195–198. https://doi.org/10.1080/10550490802021937
70.
WillcuttE. G. (2012). The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review. Neurotherapeutics, 9(3), 490–499. https://doi.org/10.1007/s13311-012-0135-8
71.
WilsonB.AldermanN.BurgessP.EmslieH.EvansE. (1996). Behavioral assessment of the dysexecutive syndrome- adult version BADS. Pearson.
72.
XiongJ.LipsitzO.NasriF.LuiL. M. W.GillH.PhanL.Chen-LiD.IacobucciM.HoR.MajeedA.McIntyreR. S. (2020). Impact of COVID-19 pandemic on mental health in the general population: A systematic review. Journal of Affective Disorders, 277, 55–64. https://doi.org/10.1016/j.jad.2020.08.001
73.
ZetterqvistJ.AshersonP.HalldnerL.LångströmN.LarssonH. (2013). Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: Total population study of trends and discontinuation patterns 2006-2009. Acta Psychiatrica Scandinavica, 128(1), 70–77. https://doi.org/10.1111/acps.12004
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
